share_log

5Needham Reiterates Buy on Bicycle Therapeutics, Maintains $38 Price Target

5Needham Reiterates Buy on Bicycle Therapeutics, Maintains $38 Price Target

Needham重申对Bicycle Therapeutics的买入评级,维持38美元的目标价。
Benzinga ·  08/07 06:39  · 评级/大行评级

Needham analyst Ami Fadia reiterates Bicycle Therapeutics (NASDAQ:BCYC) with a Buy and maintains $38 price target.

Needham分析师Ami Fadia重申买入Bicycle Therapeutics(纳斯达克:BCYC),并维持目标价格为38美元。

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发